This is a working overview of lyophilization, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-27. Anything still debated is marked as such rather than presented as settled.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
The general structure of the endoplasmic reticulum is a network of membranes called cisternae. These sac-like structures are held together by the cytoskeleton. The phospholipid membrane encloses the cisternal space (or lumen), which is continuous with the perinuclear space but separate from the cytosol. The functions of the endoplasmic reticulum can be summarized as the synthesis and export of proteins and membrane lipids, but varies between ER and cell type and cell function. The quantity of both rough and smooth endoplasmic reticulum in a cell can slowly interchange from one type to the other, depending on the changing metabolic activities of the cell. Transformation can include embedding of new proteins in membrane as well as structural changes. Changes in protein content may occur without noticeable structural changes.
This nuclide was long thought to be stable, but in 2003 it was found to be unstable, with a very long half-life of 20.1 billion billion years; it is the last step in the chain before stable thallium-205. Because this bottleneck is so long-lived, very small quantities of the final decay product have been produced, and for most practical purposes bismuth-209 is the final decay product. In the past, during the first few million years of the history of the Solar System, there were more unstable high-mass nuclides in existence, and the four chains were longer, as they included nuclides that have since decayed away. Notably, 244Pu, 237Np, and 247Cm have half-lives over a million years and would have then been bottlenecks higher in the 4n, 4n+1, and 4n+3 chains respectively - 244Pu and 247Cm have been identified as having been present. (There is no nuclide with a half-life over a million years above 238U in the 4n+2 chain.) Today some of these formerly extinct isotopes are again in existence as they have been manufactured. Thus they again take their places in the chain: plutonium-239, used in nuclear weapons, is the major example, decaying to uranium-235 via alpha emission with a half-life 24,500 years. There has also been large-scale production of neptunium-237, resurrecting the extinct fourth chain. The tables below hence start the four decay chains at isotopes of californium with mass numbers from 249 to 252.
For comparison, the rate in the general population has been found to be 1.0–1.8 per 1000 person-years, and the rate in premenopausal women taking birth control pills has been found to be 3.5 per 1000 patient-years. There was significant heterogeneity in the rates of VTE across the included studied, and the meta-analysis was unable to perform subgroup analyses between estrogen type, estrogen route, estrogen dosage, concomitant antiandrogen or progestogen use, or patient characteristics (e.g., sex, age, smoking status, weight) corresponding to known risk factors for VTE. Due to the inclusion of some studies using ethinylestradiol, which is more thrombotic and is no longer used in transgender women, the researchers noted that the VTE risk found in their study may be an overestimate. In a 2016 study that specifically assessed oral estradiol, the incidence of VTE in 676 transgender women who were treated for an average of 1.9 years each was one individual, or 0.15% of the group, with an incidence of 7.8 events per 10,000 person-years. The dosage of oral estradiol used was 2 to 8 mg/day. Almost all of the transgender women were also taking spironolactone (94%), a subset were also taking finasteride (17%), and fewer than 5% were also taking a progestogen (usually oral progesterone). The findings of this study suggest that the incidence of VTE is low in transgender women taking oral estradiol. Cardiovascular health in transgender women has been reviewed in recent publications.
=== Rugby === Five rugby clubs in Bromley are, Old Elthamians RFC (a National League 2 side), Park House FC (established in 1883), Bromley RFC (founded in 1886), Beckenham RFC (established in 1894), and Beccehamians RFC (founded in 1933) which plays competitive rugby at Sparrows Den at the bottom of Corkscrew Hill in nearby West Wickham.
== Etymology == The name pyrite is derived from the Greek πυρίτης λίθος (pyritēs lithos), 'stone or mineral which strikes fire', in turn from πῦρ (pŷr), 'fire'. In ancient Roman times, this name was applied to several types of stone that would create sparks when struck against steel; Pliny the Elder described one of them as being brassy, almost certainly a reference to what is now called pyrite. By Georgius Agricola's time, c. 1550, the term had become a generic term for all of the sulfide minerals.
Sources: en.wikipedia.org
=== DNA binding === α-Helices have particular significance in DNA binding motifs, including helix-turn-helix motifs, leucine zipper motifs and zinc finger motifs. This is because of the convenient structural fact that the diameter of an α-helix is about 12 Å (1.2 nm) including an average set of sidechains, about the same as the width of the major groove in B-form DNA, and also because coiled-coil (or leucine zipper) dimers of helices can readily position a pair of interaction surfaces to contact the sort of symmetrical repeat common in double-helical DNA. An example of both aspects is the transcription factor Max (see image at left), which uses a helical coiled coil to dimerize, positioning another pair of helices for interaction in two successive turns of the DNA major groove.
=== Act 1 === W.P. Inman, a Confederate soldier wounded at the Battle of Petersburg, decides to desert from the Confederate Army and return home to Ada Monroe, his beloved who lives at Black Cove Farm, in North Carolina. Inman is aware of the Home Guard, which hunts down deserters from the Confederate Army. The leader of the local Home Guard is Teague, who resorts to such practices as burying deserters alive. On his journey home, Inman meets Solomon Veasey, whom he stops from committing murder. Meanwhile, Ada, once privileged, leads a life of material desperation. Ada meets Ruby, a mountain woman who teaches Ada about hunting and surviving. Inman encounters Veasey again, near a river whilst fleeing the Home Guard, and bargains with him for passage across the river. However, their vessel capsizes and the two drift down the river. The next morning, Lila and her three sisters see Inman and Veasey. Lila's husband drugs the two men before giving them up to the Home Guard. Inman and Veasey are put on a chain gang of deserters. Back at Black Cove Farm, Ruby finds her estranged father, Stobrod, a fiddler. Strobod is trying to steal food. Ruby wants nothing to do with her father, although he asserts that he has reformed his ways. Teague approaches, and Ruby hides her father. She later orders her father to stay away from her. Inman starts an insurrection among the chain gang. The guards shoot the entire chain gang, with a wounded Inman as the only survivor, chained to six dead prisoners. He relives the day he bid Ada farewell, when he thought that the war would last but six months.
== Recorded human poisonings == Though fatalities from solanine poisoning are rare, there have been several notable cases of human solanine poisonings. Between 1865 and 1983, there were around 2000 documented human cases of solanine poisoning, with most recovering fully and 30 deaths. Because the symptoms are similar to those of food poisoning, it is possible that there are many undiagnosed cases of solanine toxicity. In 1899, 56 German soldiers fell ill due to solanine poisoning after consuming cooked potatoes containing 0.24 mg of solanine per gram of potato. There were no fatalities, but a few soldiers were left partially paralyzed and jaundiced. In 1918, there were 41 cases of solanine poisoning in people who had eaten a bad crop of potatoes with 0.43 mg solanine/g potato with no recorded fatalities. In Scotland in 1918, there were 61 cases of solanine poisoning after consumption of potatoes containing 0.41 mg of solanine per gram of potato, resulting in the death of a five-year old. A case report from 1925 reported that 7 family members who ate green potatoes fell ill from solanine poisoning two days later, resulting in the deaths of the 45-year-old mother and 16-year-old daughter. The other family members recovered fully. In another case report from 1959, four members of a British family exhibited symptoms of solanine poisoning after eating jacket potatoes (baked potatoes) containing 0.5 mg of solanine per gram of potato.
In May 2013 the Criminal Cases Review Commission confirmed it was re-examining the Norris case in the light of new medical and scientific evidence contradictory to that submitted to the jury during the original trial. However, in 2014, the son of victim Vera Wilby, John Barrie Wilby, said that he was "sad and upset" about the claims that Norris may be innocent, and said that he was still convinced of his guilt. In the same year there was outrage amongst elderly residents when a benefit concert was held for Norris in Dundee, with a spokesperson of the Dundee Pensioners' Forum stating: "Having a party for someone convicted of murdering all these elderly, vulnerable people is disgraceful. It's a slap in the face doing it, with all those families still grieving their loved ones". The Times declared he was one of "the 11 most evil staff in the NHS". In January 2015 the foreman of the jury that convicted Norris, after being shown the evidence in the BBC programme, said that he now believes him to be innocent; apparently the second member of the jury to do so (although this would still leave enough jury members to convict him, 10). He said that "the evidence shows a murder wasn't committed at all" (although in 2021 the CCRC concluded that Hall's case at least was indeed a clear murder).
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.